Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples